Jack Grimes is a Senior Associate at B Capital focused on life sciences investments. He evaluates biotech companies across therapeutic areas and modalities, with a focus on scientific validation and commercial potential.

Prior to B Capital, Jack was an Engagement Manager at ClearView Healthcare Partners, a biotech-focused consulting firm. At ClearView, he advised biotech companies on target selection, indication prioritization, and clinical development strategy, specializing in oncology and rare diseases. His work supported strategic decisions across M&A, licensing, and portfolio strategy.

Jack was a triple major at the University of California, Berkeley, where he earned degrees in Molecular & Cell Biology (emphasis in Genetics), Business Administration, and Spanish Linguistics. He is based in New York.